Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ingevity (NGVT) EBT Margin (2016 - 2025)

Historic EBT Margin for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to 18.67%.

  • Ingevity's EBT Margin rose 25000.0% to 18.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.25%, marking a year-over-year increase of 60100.0%. This contributed to the annual value of 38.08% for FY2024, which is 374900.0% down from last year.
  • Per Ingevity's latest filing, its EBT Margin stood at 18.67% for Q3 2025, which was up 25000.0% from 39.09% recorded in Q2 2025.
  • Ingevity's 5-year EBT Margin high stood at 20.56% for Q2 2021, and its period low was 85.66% during Q2 2024.
  • Over the past 5 years, Ingevity's median EBT Margin value was 9.9% (recorded in 2023), while the average stood at 4.04%.
  • In the last 5 years, Ingevity's EBT Margin crashed by -955600bps in 2024 and then soared by 465800bps in 2025.
  • Ingevity's EBT Margin (Quarter) stood at 10.8% in 2021, then tumbled by -52bps to 5.14% in 2022, then tumbled by -907bps to 41.43% in 2023, then crashed by -91bps to 79.0% in 2024, then skyrocketed by 124bps to 18.67% in 2025.
  • Its last three reported values are 18.67% in Q3 2025, 39.09% for Q2 2025, and 9.44% during Q1 2025.